Radiology Question for the Week of July 21, 2025
Can code 78802 be reported when performing imaging using bone agents for inflammatory disease?
Can code 78802 be reported when performing imaging using bone agents for inflammatory disease?
Can we report 78802 with 78830 if a single whole-body study and a single area SPECT or SPECT/CT are performed on the same date of service?
Are there any code edits that we should be aware of when applying LT and RT modifiers?
We are still confused about when to use or if to use the LT or RT modifier. Do you have a formula that we could apply based on a scenario?
Do you have any additional guidelines for modifiers LT and RT?
When would we report modifiers LT and RT?
Do you have any coding examples for modifier GG?
What modifiers should be submitted to ensure both a screening and diagnostic mammogram performed on the same date of service are reimbursed, and how do they help bypass NCCI edits?
Do you have any additional tips for modifier GG?
What is modifier GG, and when do we report it? Can we report it in either a professional or a hospital setting?
Can you provide any additional tips or coding examples for modifier 76?
Do you have any tips for reporting modifier 76?
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24